Cyfuse Biomedical K.K. [4892.T]
TOKYO, Apr 24 (Pulse News Wire) – Cyfuse Biomedical K.K. (4892.T) completed the payment procedures for its restricted equity compensation share issuance.
Details of the issuance were previously disclosed on March 27, 2026. For directors, the company issued 2,000 ordinary shares at ¥1,000 per share, totaling ¥2 million. Three non-outsider directors received these shares.
For executive officers, the company issued 1,000 ordinary shares at ¥2,000 per share, amounting to ¥2 million. Two executive officers who are not also directors received these shares. This issuance was approved during the board meeting held on March 27, 2026, as part of the company's restricted equity compensation program.
Interested parties can find more information in the previous announcement dated March 27, 2026.
🟢 Confidence: High AI-translated content.